Wen-Yue Liu, Xiaofang Zhang, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Rafael S. Rios, Kenneth I. Zheng, Hong-Lei Ma, Xiao-Dong Wang, Qiuwei Pan, Robert J. de Knegt, Luca Valenti, Mohsen Ghanbari, Ming-Hua Zheng
Clin Mol Hepatol 2022;28(2):183-195. Published online November 28, 2021
Background/Aims Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic dysfunction. Among the multiple factors, genetic variation acts as important modifiers. Klotho, an enzyme encoded by the klotho (KL) gene in human, has been implicated in the pathogenesis of metabolic dysfunctions. However, the impact of variants in KL on NAFLD risk remains poorly understood. The aim of this study was to investigate the impact of KL rs495392 C>A polymorphism on the histological severity of NAFLD.
Methods We evaluated the impact of the KL rs495392 polymorphism on liver histology in 531 Chinese with NAFLD and replicated that in the population-based Rotterdam Study cohort. The interactions between the rs495392, vitamin D, and patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 polymorphism were also analyzed.
Result s: Carriage of the rs495392 A allele had a protective effect on steatosis severity (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.42–0.89; P=0.010) in Chinese patients. After adjustment for potential confounders, the A allele remained significant with a protective effect (OR, 0.66; 95% CI, 0.45–0.98; P=0.040). The effect on hepatic steatosis was confirmed in the Rotterdam Study cohort. Additional analysis showed the association between serum vitamin D levels and NAFLD specifically in rs495392 A allele carriers, but not in non-carriers. Moreover, we found that the rs495392 A allele attenuated the detrimental impact of PNPLA3 rs738409 G allele on the risk of severe hepatic steatosis.
Conclusions The KL rs495392 polymorphism has a protective effect against hepatic steatosis in patients with NAFLD.
Citations
Citations to this article as recorded by
Unraveling chemotherapy-evoked hepatic dysfunction: a deep dive into cyclophosphamide-related liver injury Ehab E. Sharata, Mina Ezzat Attya, Marwa M. Khalaf, Remon Roshdy Rofaeil, Ramadan A. M. Hemeida, Amira M. Abo-Youssef Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(2): 2097. CrossRef
Non-invasive lipid panel of MASLD fibrosis transition underscores the role of lipoprotein sulfatides in hepatic immunomodulation Sin Man Lam, Zehua Wang, Jin-Wen Song, Yue Shi, Wen-Yue Liu, Lin-Yu Wan, Kaibo Duan, Gek Huey Chua, Yingjuan Zhou, Guibin Wang, Xiahe Huang, Yingchun Wang, Fu-Sheng Wang, Ming-Hua Zheng, Guanghou Shui Cell Metabolism.2025; 37(1): 69. CrossRef
Levomilnacipran alleviates cyclophosphamide-induced hepatic dysfunction in male Wistar albino rats; emerging role of α-Klotho/TLR4/p38-MAPK/NF-κB p65 and caspase-3-driven apoptosis trajectories Ehab E. Sharata, Mina Ezzat Attya, Marwa M. Khalaf, Remon Roshdy Rofaeil, Amira M. Abo-Youssef, Ramadan A.M. Hemeida International Immunopharmacology.2025; 152: 114384. CrossRef
Apremilast attenuates methotrexate-induced hepatic injury in rats; insights into TLR4/NF-κB/P38 MAPK/caspase-3 and α-klotho/Nrf2/HO-1 signaling network interplay Reham H. Mohyeldin, Ehab E. Sharata, Mahmoud Abdelnaser, Ayman M. Ibrahim, Mina Ezzat Attya, Al Shaimaa Mahmoud Kotb, Ahmed S.Aboalela, Remon Roshdy Rofaeil Toxicology and Applied Pharmacology.2025; 505: 117596. CrossRef
Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways Marwa M. Khalaf, Ehab E. Sharata, Waleed A. I. Khallaf, Mina Ezzat Attya, Amira M. Abo-Youssef, Ramadan A. M. Hemeida, Remon Roshdy Rofaeil Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef
The relationship of serum klotho levels and triglyceride glucose index-related indicators Yaoyao Zhou, Yaqi Wang, Fangli Li, Yiming Shi, Taotao Wu, Yingshuai Li Lipids in Health and Disease.2024;[Epub] CrossRef
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk Jacob Nysather, Eda Kaya, Paul Manka, Prakash Gudsoorkar, Wing-Kin Syn Advances in Kidney Disease and Health.2023; 30(4): 315. CrossRef
Emerging role of α-Klotho in energy metabolism and cardiometabolic diseases Yuanbin Liu, Mingkai Chen Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(10): 102854. CrossRef
Advances in genetic variation in metabolism-related fatty liver disease Fan Shi, Mei Zhao, Shudan Zheng, Lihong Zheng, Haiqiang Wang Frontiers in Genetics.2023;[Epub] CrossRef
Klotho Levels and Their Relationship with Inflammation and Survival among Alcoholic Patients Candelaria Martín-González, Elisa Espelosín-Ortega, Pedro Abreu-González, Camino Fernández-Rodríguez, Víctor Eugenio Vera-Delgado, Lourdes González-Navarrete, Alen García-Rodríguez, Antonio Martínez Riera, Emilio González-Reimers Biomolecules.2022; 12(8): 1151. CrossRef
CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice Rongrong Tan, Jiayang Li, Lu Liu, Qian Wu, Lei Fan, Ningning Ma, Chuwei Yu, Henglei Lu, Xuemei Zhang, Jing Chen, Likun Gong, Jin Ren International Journal of Molecular Sciences.2022; 23(24): 15931. CrossRef
Background/Aims Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of a key biomarker, lipocalin-2 (LCN2), for the detection of NASH progression.
Methods A mouse NASH model was established using a high-fat diet and a high-sugar drinking water. Gene expression profile of the NASH model was analyzed using RNA sequencing. Moreover, 360 NAFLD patients (steatosis, 83; NASH, 277), 40 healthy individuals, and 87 patients with alcoholic fatty liver disease were recruited.
Result s: Inflammatory infiltration, focal necrosis in the leaflets, steatosis, and fibrosis were documented in the mouse liver. In total, 504 genes were differentially expressed in the livers of NASH mice, and showed significant functional enrichment in the inflammation-related category. Upregulated liver LCN2 was found to be significantly interactive with various interleukins and toll-like receptors. Serum LCN2 levels were significantly increased in NAFLD patients. Serum LCN2 levels were correlated with steatosis, intralobular inflammation, semiquantitative fibrosis score, and nonalcoholic fatty liver disease activity score. The area under the curve of serum LCN2 was 0.987 with a specificity of 100% and a sensitivity of 93.5% for NASH diagnosis, and 0.977 with almost the same specificity and sensitivity for steatosis.
Conclusions LCN2 might be involved in the transition from NAFL to NASH by mediating inflammation. Serum LCN2 levels might be a novel biomarker for the diagnosis of NASH.
Citations
Citations to this article as recorded by
Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction–associated steatohepatitis in mice Veronia Basaly, Zakiyah R. Henry, Rulaiha E. Taylor, Bo Kong, Ill Yang, Anita Brinker, Zhenning Yang, Peihong Zhou, Laurie B. Joseph, Lauren Aleksunes, Brian Buckley, Masahiko Negishi, Grace L. Guo Drug Metabolism and Disposition.2026; 54(2): 100222. CrossRef
A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease Guilherme Ribeiro Romualdo, Letícia C. Valente, Gabriel P. Bacil, Luana Riechelmann-Casarin, Antônio R. B. da Fonseca, Miguel W. Fornes, Luís F. Barbisan Journal of Molecular Histology.2025;[Epub] CrossRef
Role of Neutrophils in Homeostasis and Diseases Xingyu Chang, Yulin Liu, Junjun Qiu, Keqin Hua MedComm.2025;[Epub] CrossRef
The Role of an Elevated Fibrosis‐4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction‐Associated Steatotic Liver Disease Maiko Nagaoka, Katsuya Nagaoka, Naoto Kajitani, Kazuhiro Yoshiura, Yoko Yoshimaru, Takehisa Watanabe, Hiroko Setoyama, Noboru Fujise, Minoru Takebayashi, Yasuhito Tanaka Geriatrics & Gerontology International.2025; 25(12): 1903. CrossRef
Genetic and Molecular Profiling of PLIN5 and LCN2 in Hepatocellular Carcinoma: Implications for Diagnosis and Prognosis Mahsa Sadat Reypour, Bita Moudi, Massoud Houshmand, Seyyedeh Behnaz Motahari International Journal of Infection.2025;[Epub] CrossRef
Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections Feng Chen, Shan-Shan Wu, Chao Chen, Cheng Zhou World Journal of Hepatology.2024; 16(2): 177. CrossRef
Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2 Eun-Ho Lee, Jae-Ho Lee, Do-Young Kim, Young-Seung Lee, Yunju Jo, Tam Dao, Kyung Eun Kim, Dae-Kyu Song, Ji Hae Seo, Young-Kyo Seo, Je Kyung Seong, Changjong Moon, Eugene Han, Mi Kyung Kim, Seungwan Ryu, Minsang Shin, Gu Seob Roh, Hye Ra Jung, Timothy F. Os Experimental & Molecular Medicine.2024; 56(4): 1001. CrossRef
The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction‐associated steatotic liver disease Ina Bergheim, José María Moreno‐Navarrete European Journal of Clinical Investigation.2024;[Epub] CrossRef
Diagnostic and prognostic value of plasma lipocalin-2 levels in patients with metabolic dysfunction–associated steatotic liver disease Ahmed Mohamed ElGhandour, Nahla Mohamed Teama, Marwa Abdullah Kamal, Ehab Hassan Nashaat, Amani Mohamed Abdel Ghani, Ahmad Abbas Abdo Egyptian Liver Journal.2024;[Epub] CrossRef
Lipocalin-2 levels increase in plasma of non-alcoholic fatty liver disease patients with metabolic syndrome Hirdesh Chawla, Vivek Bhosale, Ravi Misra, Satyendra Kumar Sonkar, Neera Kohli, Naseem Jamal, Shobhit Raj Vimal, Banwari Dangi, Kavita Durgapal, Shail Singh, Mahendra Pal Singh Negi, Ashim Ghatak International Journal of Diabetes in Developing Countries.2023; 43(1): 105. CrossRef
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets Liu Yang, Yawen Hao, Joost Boeckmans, Robim M. Rodrigues, Yong He Pharmacology & Therapeutics.2023; 243: 108353. CrossRef
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne Clinical and Molecular Hepatology.2023; 29(Suppl): S157. CrossRef
LCN2 contributes to the improvement of nonalcoholic steatohepatitis by 8-Cetylberberine Huan He, Xue Chai, Juan Li, Changsheng Li, Xinran Wu, Xiaoli Ye, Hang Ma, Xuegang Li Life Sciences.2023; 321: 121595. CrossRef
Lipocalin-2 Secreted by the Liver Regulates Neuronal Cell Function Through AKT-Dependent Signaling in Hepatic Encephalopathy Mouse Model Danbi Jo, Yoon Seok Jung, Juhyun Song Clinical Nutrition Research.2023; 12(2): 154. CrossRef
From NAFLD to HCC: Advances in noninvasive diagnosis Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang Biomedicine & Pharmacotherapy.2023; 165: 115028. CrossRef
The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery Jiaqi Chen, Shihui Lei, Yueye Huang, Xiaojuan Zha, Lei Gu, Donglei Zhou, Jun Li, Feng Liu, Nannan Li, Lei Du, Xiu Huang, Ziwei Lin, Le Bu, Shen Qu Lipids in Health and Disease.2022;[Epub] CrossRef
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis Ki Wung Chung, Ye Eun Cho, Seung-Jin Kim, Seonghwan Hwang Archives of Pharmacal Research.2022; 45(4): 229. CrossRef
Bioinformatics analysis reveals the changes of peroxisome proliferator-activated receptor (PPAR) pathway in the development of Marjolin ulcers Cheng Wang, Lin Cheng, Ying Zhang, Xiaozhuo Zhao, Huijun Zhang, Yuming Shen All Life.2022; 15(1): 960. CrossRef
A multi-omic landscape of steatosis-to-NASH progression Liping Xiang, Xiaoyan Li, Yunchen Luo, Bing Zhou, Yuejun Liu, Yao Li, Duojiao Wu, Lijing Jia, Pei-Wu Zhu, Ming-Hua Zheng, Hua Wang, Yan Lu Life Metabolism.2022; 1(3): 242. CrossRef
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Marinela Krizanac, Paola Berenice Mass Sanchez, Ralf Weiskirchen, Anastasia Asimakopoulos International Journal of Molecular Sciences.2021; 22(6): 2865. CrossRef
Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, Ye Eun Cho, Bin Gao Frontiers in Endocrinology.2021;[Epub] CrossRef
First
Prev
